- 专利标题： CRYSTALLINE OR AMORPHOUS FORM OF STEROID DERIVATIVE FXR AGONIST, PREPARATION METHOD THEREFOR AND USE THEREOF
-
申请号： US16633111申请日： 2018-07-26
-
公开(公告)号： US20200231621A1公开(公告)日： 2020-07-23
- 发明人: Xiaolin Li , Hualing Xiao , Peng Li , Haiying He , Weidong Li
- 申请人： Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- 优先权： com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@77192a90
- 国际申请： PCT/CN2018/097161 WO 20180726
- 主分类号： C07J43/00
- IPC分类号： C07J43/00
摘要：
Disclosed are a crystalline or amorphous form of steroid derivative FXR agonist (formula I), and a preparation method therefor, and a crystalline composition and pharmaceutical composition comprising the crystalline or amorphous form, and the use of same in the preparation of a drug for treating or preventing various conditions associated with FXR.
公开/授权文献
信息查询
